Home > Resources > Videos > Residual Disease and Immune Dysfunction: A Growing Risk of Relapse Forms in Multiple Myeloma

Residual Disease and Immune Dysfunction: A Growing Risk of Relapse Forms in Multiple Myeloma

Multiple myeloma remains a relatively complex and incurable disease. Despite improvements in 5-year survival, most patients who are in remission eventually relapse as a result of residual disease. In this segment Dr. Ravi Vij, Associate Professor at Washington University School of Medicine, explains how residual disease and immune dysfunction contribute to multiple myeloma progression.

Spotlight

Kalon Biotherapeutics, LLC

FUJIFILM Diosynth Biotechnologies Texas operates the National Center for Therapeutics Manufacturing (NCTM), offering flexible manufacturing environments and technologies to biological therapeutics. The center includes 110,000 square feet of cGMP space, and houses 20 modular cleanrooms. The NCTM’s facilities are state-of-the-art and are ideal for biotherapeutics research, development, workforce training and GMP manufacturing.

OTHER VIDEOS

The Cardinal Health™ InteLogix™ Platform

video | September 6, 2023

Learn about the industry’s first pharmaceutical supply chain solution that is reducing the cost of care and ensuring access to critical medications for hospitals and health systems....

Watch Now

Aeris: Benchtop XRD for pharmaceutical solid form analysis

video | August 28, 2023

Is solid form characterization critical in your line of work, but you lack expertise in X-ray diffraction (XRD)? Do you need an efficient tool to support you with lead optimization? Do you need an easy way to validate the stability of your solid form following processing?...

Watch Now

Semi-automated testing of on-body delivery systems (OBDS)

video | August 17, 2023

Injection systems that are attached to the patient's body (on-body delivery system OBDS) minimize possible risks, that can occur when drugs are administered by conventional needle-based injection systems (NIS)....

Watch Now

Line Optimizer - digital guided workflows for optimized pharma production operations

video | May 26, 2023

Connectivity in general is becoming an ever more important consideration for production facilities as we endeavour to produce more with less and all the while trying to satisfy an increasing need for more information and communication to and from the production equipment itself....

Watch Now

The Cardinal Health™ InteLogix™ Platform

video | September 6, 2023

Learn about the industry’s first pharmaceutical supply chain solution that is reducing the cost of care and ensuring access to critical medications for hospitals and health systems....

Watch Now

Aeris: Benchtop XRD for pharmaceutical solid form analysis

video | August 28, 2023

Is solid form characterization critical in your line of work, but you lack expertise in X-ray diffraction (XRD)? Do you need an efficient tool to support you with lead optimization? Do you need an easy way to validate the stability of your solid form following processing?...

Watch Now

Semi-automated testing of on-body delivery systems (OBDS)

video | August 17, 2023

Injection systems that are attached to the patient's body (on-body delivery system OBDS) minimize possible risks, that can occur when drugs are administered by conventional needle-based injection systems (NIS)....

Watch Now

Line Optimizer - digital guided workflows for optimized pharma production operations

video | May 26, 2023

Connectivity in general is becoming an ever more important consideration for production facilities as we endeavour to produce more with less and all the while trying to satisfy an increasing need for more information and communication to and from the production equipment itself....

Watch Now
MORE VIDEOS

Spotlight

Kalon Biotherapeutics, LLC

FUJIFILM Diosynth Biotechnologies Texas operates the National Center for Therapeutics Manufacturing (NCTM), offering flexible manufacturing environments and technologies to biological therapeutics. The center includes 110,000 square feet of cGMP space, and houses 20 modular cleanrooms. The NCTM’s facilities are state-of-the-art and are ideal for biotherapeutics research, development, workforce training and GMP manufacturing.

Events